Sale!

Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test

Original price was: $376.Current price is: $226.

-40%

The Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test is a specialized diagnostic tool that detects antibodies targeting myelin oligodendrocyte glycoprotein (MOG), a crucial protein in the central nervous system. This test plays a vital role in identifying autoimmune conditions affecting the brain and spinal cord, particularly MOG antibody-associated disease (MOGAD). Patients experiencing neurological symptoms such as optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis benefit from this precise diagnostic approach. The test utilizes advanced cell-based assay technology with immunofluorescence detection for superior accuracy. With same-day reporting available and no special preparation required, this $226 USD test provides critical insights for neurologists managing complex autoimmune neurological disorders. Early detection through this testing can lead to timely intervention and improved patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test

Understanding Anti-MOG Antibody Testing

The Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test represents a breakthrough in neurological autoimmune diagnostics. This specialized test detects antibodies directed against myelin oligodendrocyte glycoprotein (MOG), a critical protein component of the central nervous system’s myelin sheath. MOG plays an essential role in maintaining the structural integrity and proper functioning of nerve fibers throughout the brain and spinal cord.

When the immune system mistakenly produces antibodies against MOG, it can trigger inflammatory demyelinating conditions that disrupt normal neurological function. The identification of these specific antibodies has revolutionized the diagnosis and management of several autoimmune neurological disorders, providing clinicians with precise diagnostic markers that guide targeted treatment strategies.

What Does the Anti-MOG Test Measure?

This advanced diagnostic test specifically measures immunoglobulin G (IgG) antibodies that target myelin oligodendrocyte glycoprotein in the patient’s serum. The test employs sophisticated cell-based assay technology combined with immunofluorescence detection methods to ensure exceptional accuracy and reliability.

  • Target Detection: Identifies anti-MOG IgG antibodies in blood serum
  • Methodology: Cell-based assay with immunofluorescence (IFA) technology
  • Sample Requirements: 2 mL serum from one serum separator tube
  • Turnaround: Same-day reporting when samples arrive Tuesday or Friday by 9 AM

Who Should Consider Anti-MOG Testing?

This test is particularly valuable for individuals experiencing symptoms suggestive of inflammatory demyelinating disorders of the central nervous system. Patients presenting with the following neurological manifestations should discuss Anti-MOG testing with their healthcare provider:

Primary Clinical Indications

  • Optic neuritis with atypical features or recurrent episodes
  • Transverse myelitis affecting spinal cord function
  • Acute disseminated encephalomyelitis (ADEM) symptoms
  • Neurological symptoms following viral infections or vaccinations
  • Unexplained brainstem or cerebral hemisphere inflammation
  • Recurrent neurological episodes without clear diagnosis

Symptom Profile for Testing Consideration

  • Vision disturbances including blurred vision, color desaturation, or eye pain
  • Motor weakness or sensory changes in limbs
  • Balance difficulties and coordination problems
  • Cognitive changes or altered mental status
  • Bowel or bladder dysfunction of neurological origin

Clinical Benefits of Anti-MOG Testing

Undergoing Anti-MOG antibody testing provides numerous advantages for both patients and healthcare providers in managing complex neurological conditions:

Diagnostic Precision

  • Differentiates MOG antibody-associated disease from other demyelinating disorders
  • Provides definitive biomarker evidence for autoimmune neurological conditions
  • Helps distinguish from multiple sclerosis and neuromyelitis optica spectrum disorder

Treatment Guidance

  • Informs targeted immunotherapy selection and timing
  • Guides decisions regarding long-term immunosuppressive therapy
  • Helps predict treatment response and disease course

Prognostic Value

  • Assists in predicting relapse risk and disease progression
  • Provides insights into potential treatment complications
  • Helps establish appropriate monitoring frequency

Understanding Your Test Results

Interpreting Anti-MOG antibody test results requires careful consideration by qualified neurologists and immunopathology specialists. Here’s general guidance on understanding your results:

Positive Results

A positive Anti-MOG antibody test indicates the presence of antibodies targeting myelin oligodendrocyte glycoprotein. This finding strongly supports the diagnosis of MOG antibody-associated disease (MOGAD). Positive results typically correlate with specific clinical presentations and may guide immediate treatment decisions, including immunotherapy initiation.

Negative Results

Negative results suggest the absence of detectable anti-MOG antibodies in the current sample. However, this does not completely rule out all autoimmune neurological conditions, as timing of testing relative to symptom onset and treatment effects can influence results. Your neurologist will interpret negative findings in the context of your complete clinical picture.

Quantitative Interpretation

Some laboratories provide quantitative antibody titers, where higher levels may correlate with more active disease or specific clinical manifestations. Your specialist will consider the antibody titer alongside your symptoms, imaging findings, and other laboratory results to develop a comprehensive management plan.

Test Pricing and Availability

Test Description Price Type Amount (USD)
Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test Discount Price $226
Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test Regular Price $376

Nationwide Testing Accessibility

We maintain comprehensive testing facilities across the United States to ensure convenient access to specialized neurological diagnostics. Our network includes fully-equipped laboratories in:

  • New York metropolitan area
  • Los Angeles and Southern California
  • Chicago and Midwest regions
  • Houston and Texas locations
  • Phoenix and Southwest facilities
  • All other major metropolitan areas nationwide

Schedule Your Anti-MOG Test Today

Take the first step toward precise neurological diagnosis and personalized treatment planning. Our specialized immunopathology department, working in collaboration with leading neurologists, provides comprehensive Anti-MOG antibody testing with rapid turnaround times and expert interpretation.

Call our dedicated neurological testing line at +1(267) 388-9828 to schedule your appointment or discuss testing options with our specialist coordinators. We offer convenient sample collection, same-day reporting capabilities, and seamless coordination with your healthcare team to ensure optimal patient care.

Early detection of autoimmune neurological conditions through precise antibody testing can significantly impact treatment outcomes and quality of life. Contact us today to arrange your Anti-MOG Myelin Oligodendrocyte Glycoprotein Serum Test and take control of your neurological health.